Articles with public access mandates - Mark BehlkeLearn more
OverallNIHNHMRCFRQSSwedish Research CouncilARCMRCCIHREuropean CommissionWellcomeBBSRCEPSRCGovernment of SpainNSFHHMINSERCCPRITVAAHANSFCDFGTelethonCancer Research UKMotor Neurone Disease Association, UKNIHRDoris Duke Charitable FoundationState of CalifoniaBMBFUK Research & InnovationBrain Tumour Charity, UKHFSP
Not available anywhere: 4
Gene silencing by synthetic U1 adaptors
R Goraczniak, MA Behlke, SI Gunderson
Nature biotechnology 27 (3), 257-263, 2009
Mandates: US National Institutes of Health
Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells
M Zamanian-Daryoush, JT Marques, MP Gantier, MA Behlke, M John, ...
Journal of Interferon & Cytokine Research 28 (4), 221-233, 2008
Mandates: US National Institutes of Health
Gβ4γ1 as a modulator of M3 muscarinic receptor signalling and novel roles of Gβ1 subunits in the modulation of cellular signalling
SM Khan, A Min, S Gora, GM Houranieh, R Campden, M Robitaille, ...
Cellular signalling 27 (8), 1597-1608, 2015
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Four novel splice-switch reporter cell lines: distinct impact of oligonucleotide chemistry and delivery vector on biological activity
CSJ Rocha, KE Lundin, MA Behlke, R Zain, S El Andaloussi, CIE Smith
nucleic acid therapeutics 26 (6), 381-391, 2016
Mandates: Swedish Research Council
Available somewhere: 88
Identification of preexisting adaptive immunity to Cas9 proteins in humans
CT Charlesworth, PS Deshpande, DP Dever, J Camarena, VT Lemgart, ...
Nature medicine 25 (2), 249-254, 2019
Mandates: US National Institutes of Health
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
CA Vakulskas, DP Dever, GR Rettig, R Turk, AM Jacobi, MA Collingwood, ...
Nature medicine 24 (8), 1216-1224, 2018
Mandates: US National Institutes of Health
Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins
RM Quadros, H Miura, DW Harms, H Akatsuka, T Sato, T Aida, R Redder, ...
Genome biology 18, 1-15, 2017
Mandates: US National Institutes of Health, Wellcome Trust
Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress
CI Michel, CL Holley, BS Scruggs, R Sidhu, RT Brookheart, ...
Cell metabolism 14 (1), 33-44, 2011
Mandates: US National Institutes of Health
A modular platform for targeted RNAi therapeutics
R Kedmi, N Veiga, S Ramishetti, M Goldsmith, D Rosenblum, N Dammes, ...
Nature nanotechnology 13 (3), 214-219, 2018
Mandates: European Commission
In vivo SELEX for Identification of Brain-penetrating Aptamers
C Cheng, YH Chen, KA Lennox, MA Behlke, BL Davidson
Molecular Therapy-Nucleic Acids 2, 2013
Mandates: US National Institutes of Health
A miR-19 regulon that controls NF-κB signaling
MP Gantier, HJ Stunden, CE McCoy, MA Behlke, D Wang, ...
Nucleic acids research 40 (16), 8048-8058, 2012
Mandates: National Health and Medical Research Council, Australia
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ...
Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Highly efficient CRISPR-Cas9-based methods for generating deletion mutations and F0 embryos that lack gene function in zebrafish
K Hoshijima, MJ Jurynec, DK Shaw, AM Jacobi, MA Behlke, DJ Grunwald
Developmental cell 51 (5), 645-657. e4, 2019
Mandates: US National Institutes of Health
Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier
KA Lennox, R Owczarzy, DM Thomas, JA Walder, MA Behlke
Molecular Therapy-Nucleic Acids 2, 2013
Mandates: US National Institutes of Health
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes
AM Jacobi, GR Rettig, R Turk, MA Collingwood, SA Zeiner, RM Quadros, ...
Methods 121, 16-28, 2017
Mandates: US National Institutes of Health
Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs
MA Collingwood, SD Rose, L Huang, C Hillier, M Amarzguioui, MT Wiiger, ...
Oligonucleotides 18 (2), 187-200, 2008
Mandates: US National Institutes of Health
Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection
WH Thiel, T Bair, AS Peek, X Liu, J Dassie, KR Stockdale, MA Behlke, ...
Public Library of Science 7 (9), e43836, 2012
Mandates: US National Institutes of Health
A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator
S Ramachandran, PH Karp, P Jiang, LS Ostedgaard, AE Walz, JT Fisher, ...
Proceedings of the National Academy of Sciences 109 (33), 13362-13367, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe
FJ Hernandez, L Huang, ME Olson, KM Powers, LI Hernandez, ...
Nature medicine 20 (3), 301-306, 2014
Mandates: US National Institutes of Health
Engineered transfer RNAs for suppression of premature termination codons
JD Lueck, JS Yoon, A Perales-Puchalt, AL Mackey, DT Infield, MA Behlke, ...
Nature communications 10 (1), 822, 2019
Mandates: US National Institutes of Health, American Heart Association
Publication and funding information is determined automatically by a computer program